Similar Posts
Emergent Biosolutions Hits New 52-Week High On Positive Outlook
Mayur Pahilajani – iStockAnalyst WriterNew York, NY Shares of Emergent Biosolutions Inc (NYSE: EBS) topped 52-week mark after the bell on Friday as investors gained confidence in the company after the Rockville-based biotech’s profitable anthrax treatments won emergency protection. On October 9, the firm announced that the vaccine Biothrax and its Anthrax Immune Globulin, both…
New California law lets 12-year-olds consent to “preventive care for STDs” aka Gardasil/ LA Times
From the LA Times: California Gov. Jerry Brown stepped into the middle of a debate over parental rights Sunday by signing legislation giving children 12 or older the power to consent to medical care involving the prevention of sexually transmitted disease. Asssemblywoman Toni Atkins (D-San Diego) sponsored AB 499 with the aim of providing young…
Flu Season Off to Slow Start, So Far/ US News
From US News and World Report: Relatively few cases reported, experts say, but that doesn’t mean a surge can’t happen… One barometer of flu activity, the percentage of visits to hospitals or doctors’ offices linked to influenza, also suggests a mild season so far. For example, just 1.4 percent of outpatient visits during the week…
“inactive” ingredients in medications can and do make people sick
A premier science journal, Science Translational Medicine, pointed out that extraneous substances in medications can and do make people sick–in an article written by scientists at MIT and published March 13, 2019. Why would anyone assume the same is not true of vaccines? “Inactive” ingredients in oral medications 1. Daniel Reker1,2,3,*, 2. Steven M. Blum1,4,5,*, …
Deviations from “Good Manufacturing Practices” the rule/ the Australian
An FDA inspection uncovered multiple significant deviations from standard manufacturing processes, termed “good manufacturing practices” at CSL (previously known as Commonwealth Serum Laboratories, and previously an Australian government lab) in its manufacture of flu vaccine for the US market. As is standard in these cases, a disclaimer was made to the effect that there is…
Papers of Record Unsatisfied
Washington Post and New York Times editorials today find the FBI’s revelations unconvincing, and call for an independent, scientific review of the evidence.